Ret in human development and oncogenesis
- 1 May 1997
- Vol. 19 (5), 389-395
- https://doi.org/10.1002/bies.950190506
Abstract
Hirschsprung disease and the multiple endocrine neoplasia type 2 syndromes are hereditary disorders related to the abnormal migration, proliferation or survival of neural crest cells and their derivatives. Hirschsprung disease is a frequent disorder of the enteric nervous system, resulting in intestinal obstruction. The multiple endocrine neoplasia type 2 syndromes predispose to cancers of neural crest derivatives. Both diseases are associated with heterozygous mutations in the RET proto‐oncogene. RET encodes a transmembrane receptor tyrosine kinase expressed in neural crest lineages and whose ligand, glial‐cell‐line‐derived neurotrophic factor, has been very recently identified. In vitro expression studies demonstrate that while Hirschsprung disease mutations result in loss of function of the mutant RET tyrosine kinase, multiple endocrine neoplasia type 2 mutations lead to its constitutive activation. Thus, the two ‘faces’ of RET, gain of function and loss of function, each lead to a different syndrome, respectively: multiple endocrine neoplasia type 2, a cancer syndrome, or Hirschsprung disease, a developmental defect.Keywords
This publication has 60 references indexed in Scilit:
- Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.Journal of Medical Genetics, 1995
- Analysis ofRET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomasCancer, 1995
- Loss of function effect of RET mutations causing Hirschsprung diseaseNature Genetics, 1995
- Mutations in the RET protooncogene in sporadic pheochromocytomasJournal of Clinical Endocrinology & Metabolism, 1995
- Catalytic specificity of protein-tyrosine kinases is critical for selective signallingNature, 1995
- Hirschsprung's disease associated with a deletion of chromosome 10 (q11.2q21.2): a further link with the neurocristopathies?Journal of Medical Genetics, 1994
- Expression of the ret proto‐oncogene product in human normal and neoplastic tissues of neural crest originThe Journal of Pathology, 1994
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993
- Localisation of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2Human Molecular Genetics, 1993
- RISK ESTIMATION AND SCREENING IN FAMILIES OF PATIENTS WITH MEDULLARY THYROID CARCINOMAThe Lancet, 1988